How social stress and brain immune responses can increase alcohol drinking
Corticolimbic Neuroimmune Determinants of Social Stress-Associated Alcohol Drinking
This work looks at how social stress might change immune activity in stress‑sensitive brain areas and make people more likely to drink heavily after stressful social situations.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11158870 on NIH RePORTER |
What this research studies
This project uses animal models to explore why social stress—like low social rank or isolation—leads some individuals to drink more alcohol. Researchers will measure drinking behavior in mice while examining stress‑responsive brain regions such as the amygdala and connected cortical areas. The team will study microglia (the brain’s immune cells) and other neuroimmune signals and compare animals of different social ranks and after isolation. Results will guide follow‑up work toward drugs or other treatments that could block harmful brain immune responses linked to stress‑related heavy drinking.
Who could benefit from this research
Good fit: Adults who tend to drink more after social stress, people with anxiety‑linked drinking, or those with a history of heavy alcohol use would be most relevant to this research.
Not a fit: People whose drinking is driven mainly by factors other than social stress—such as medical dependence, metabolic issues, or non‑stress motives—may not benefit directly from these findings.
Why it matters
Potential benefit: If successful, this work could point to brain immune targets for new treatments to prevent or reduce stress‑driven heavy drinking and related alcohol use disorder.
How similar studies have performed: Prior animal studies suggest brain immune cells affect stress responses and alcohol use, but translating those results into proven human treatments is still largely untested.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Patel, Reesha — Northwestern University
- Study coordinator: Patel, Reesha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.